Header Logo

Connection

THOMAS W BURKE to Adult

Back to Details
This is a "connection" page, showing publications THOMAS W BURKE has written about Adult.
THOMAS W BURKE
Connection Strength
0.294
Adult
  1. Developing a system to track meaningful outcome measures in head and neck cancer treatment. Head Neck. 2014 Feb; 36(2):226-30.
    View in: PubMed
    Score: 0.018
  2. A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium. Gynecol Oncol. 2013 May; 129(2):304-9.
    View in: PubMed
    Score: 0.018
  3. Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma. Cancer. 2009 May 01; 115(9):1867-74.
    View in: PubMed
    Score: 0.014
  4. Uncovering the historic environmental hazards of urban brownfields. J Urban Health. 2002 Dec; 79(4):464-81.
    View in: PubMed
    Score: 0.009
  5. Utility of lymphangiography in the prediction of lymph node metastases in patients with cervical cancer. Int J Gynecol Cancer. 2002 Nov-Dec; 12(6):755-9.
    View in: PubMed
    Score: 0.009
  6. Examining urban brownfields through the public health "macroscope". Environ Health Perspect. 2002 Apr; 110 Suppl 2:183-93.
    View in: PubMed
    Score: 0.008
  7. Reliability, validity, and responsiveness of severity of dyspepsia assessment (SODA) in a randomized clinical trial of a COX-2-specific inhibitor and traditional NSAID therapy. Am J Gastroenterol. 2002 Jan; 97(1):32-9.
    View in: PubMed
    Score: 0.008
  8. A comparison of host response strategies to distinguish bacterial and viral infection. PLoS One. 2021; 16(12):e0261385.
    View in: PubMed
    Score: 0.008
  9. Transverse colon urinary diversion in gynecologic oncology. Gynecol Oncol. 1996 Oct; 63(1):66-70.
    View in: PubMed
    Score: 0.006
  10. Combination chemotherapy with hydroxyurea, dacarbazine (DTIC), and etoposide in the treatment of uterine leiomyosarcoma: a Gynecologic Oncology Group study. Gynecol Oncol. 1996 Apr; 61(1):27-30.
    View in: PubMed
    Score: 0.005
  11. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol Oncol. 1995 May; 57(2):215-20.
    View in: PubMed
    Score: 0.005
  12. Perineal reconstruction using single gracilis myocutaneous flaps. Gynecol Oncol. 1995 May; 57(2):221-5.
    View in: PubMed
    Score: 0.005
  13. Closure of complex vulvar defects using local rhomboid flaps. Obstet Gynecol. 1994 Dec; 84(6):1043-7.
    View in: PubMed
    Score: 0.005
  14. Salvage surgery for chemorefractory ovarian germ cell tumors. Gynecol Oncol. 1994 Nov; 55(2):217-23.
    View in: PubMed
    Score: 0.005
  15. Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma. Gynecol Oncol. 1994 Oct; 55(1):47-50.
    View in: PubMed
    Score: 0.005
  16. Metastatic cervical cancer presenting as cholecystitis. Gynecol Oncol. 1994 Aug; 54(2):250-3.
    View in: PubMed
    Score: 0.005
  17. The KRAS-variant and miRNA expression in RTOG endometrial cancer clinical trials 9708 and 9905. PLoS One. 2014; 9(4):e94167.
    View in: PubMed
    Score: 0.005
  18. Enterovesical fistula following radiotherapy for gynecologic cancer. Gynecol Oncol. 1994 Mar; 52(3):296-300.
    View in: PubMed
    Score: 0.005
  19. Treatment of advanced or recurrent endometrial carcinoma with single-agent carboplatin. Gynecol Oncol. 1993 Dec; 51(3):397-400.
    View in: PubMed
    Score: 0.005
  20. Factors affecting recurrence and survival in stage I carcinoma of the uterine cervix. Oncology (Williston Park). 1992 Feb; 6(2):111-6; discussion 118-9; 122.
    View in: PubMed
    Score: 0.004
  21. Radical wide excision and selective inguinal node dissection for squamous cell carcinoma of the vulva. Gynecol Oncol. 1990 Sep; 38(3):328-32.
    View in: PubMed
    Score: 0.004
  22. A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma. Cancer. 2010 Dec 01; 116(23):5415-9.
    View in: PubMed
    Score: 0.004
  23. Treatment failure in endometrial carcinoma. Obstet Gynecol. 1990 Jan; 75(1):96-101.
    View in: PubMed
    Score: 0.004
  24. Continuous thoracic epidural analgesia for the control of pain associated with pleural sclerosis. Gynecol Oncol. 1989 Jan; 32(1):76-8.
    View in: PubMed
    Score: 0.003
  25. Evaluation of the scalene lymph nodes in primary and recurrent cervical carcinoma. Gynecol Oncol. 1987 Nov; 28(3):312-7.
    View in: PubMed
    Score: 0.003
  26. Prognostic factors associated with radical hysterectomy failure. Gynecol Oncol. 1987 Feb; 26(2):153-9.
    View in: PubMed
    Score: 0.003
  27. End colostomy using the end-to-end anastomosis instrument. Obstet Gynecol. 1987 Feb; 69(2):156-9.
    View in: PubMed
    Score: 0.003
  28. Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecol Oncol. 2007 Jan; 104(1):100-3.
    View in: PubMed
    Score: 0.003
  29. The use of adjuvant radiation therapy in patients with intermediate-risk Stages IC and II uterine corpus cancer: a patient care evaluation study from the American College of Surgeons National Cancer Data Base. Gynecol Oncol. 2005 Dec; 99(3):530-5.
    View in: PubMed
    Score: 0.003
  30. Development of metastatic endometrial endometrioid adenocarcinoma while on progestin therapy for endometrial hyperplasia. Gynecol Oncol. 2005 Nov; 99(2):472-6.
    View in: PubMed
    Score: 0.003
  31. The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors. Gynecol Oncol. 2005 May; 97(2):489-96.
    View in: PubMed
    Score: 0.003
  32. Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapy. Int J Gynecol Cancer. 2005 May-Jun; 15(3):510-6.
    View in: PubMed
    Score: 0.003
  33. The impact of losartan on the lifetime incidence of ESRD and costs in Mexico. Rev Invest Clin. 2005 May-Jun; 57(3):399-405.
    View in: PubMed
    Score: 0.003
  34. Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol. 2005 Mar; 105(3):569-74.
    View in: PubMed
    Score: 0.003
  35. Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol. 2005 Mar; 105(3):575-80.
    View in: PubMed
    Score: 0.003
  36. Retrospective review: re-treatment of patients with ovarian cancer with carboplatin after platinum resistance. Int J Gynecol Cancer. 2005 Mar-Apr; 15(2):209-16.
    View in: PubMed
    Score: 0.003
  37. The activity of taxanes in the treatment of sex cord-stromal ovarian tumors. J Clin Oncol. 2004 Sep 01; 22(17):3517-23.
    View in: PubMed
    Score: 0.002
  38. Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantation. Bone Marrow Transplant. 2004 Jun; 33(12):1219-24.
    View in: PubMed
    Score: 0.002
  39. Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk. Cancer Epidemiol Biomarkers Prev. 2004 May; 13(5):748-52.
    View in: PubMed
    Score: 0.002
  40. Malignant mixed M?llerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome. Int J Radiat Oncol Biol Phys. 2004 Mar 01; 58(3):786-96.
    View in: PubMed
    Score: 0.002
  41. Characteristics of recurrence in patients who underwent lymphatic mapping for vulvar cancer. Gynecol Oncol. 2004 Jan; 92(1):205-10.
    View in: PubMed
    Score: 0.002
  42. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol Oncol. 2003 Dec; 91(3):463-9.
    View in: PubMed
    Score: 0.002
  43. A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed m?llerian tumors with evaluation of potential molecular targets. Gynecol Oncol. 2003 Sep; 90(3):529-36.
    View in: PubMed
    Score: 0.002
  44. Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy. Gynecol Oncol. 2003 Sep; 90(3):625-8.
    View in: PubMed
    Score: 0.002
  45. Uterine tumor resembling ovarian sex-cord tumor: report of a case mimicking cervical adenocarcinoma. Int J Gynecol Pathol. 2003 Jul; 22(3):297-302.
    View in: PubMed
    Score: 0.002
  46. Sarcomatoid carcinoma of the cervix. Gynecol Oncol. 2003 Jul; 90(1):23-8.
    View in: PubMed
    Score: 0.002
  47. A phase II trial of arzoxifene, a selective estrogen response modulator, in patients with recurrent or advanced endometrial cancer. Gynecol Oncol. 2003 Jul; 90(1):64-9.
    View in: PubMed
    Score: 0.002
  48. Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol. 2001 Nov; 83(2):276-81.
    View in: PubMed
    Score: 0.002
  49. Sigmoid perforation following radiation therapy in patients with cervical cancer. Gynecol Oncol. 2001 Jul; 82(1):150-5.
    View in: PubMed
    Score: 0.002
  50. High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer. Bone Marrow Transplant. 2000 Jun; 25(11):1137-40.
    View in: PubMed
    Score: 0.002
  51. A phase I trial of intravenous melphalan, paclitaxel, and cisplatin plus granulocyte-colony stimulating factor in patients with suboptimal advanced epithelial ovarian carcinoma or peritoneal carcinoma. Cancer. 1999 Dec 01; 86(11):2291-300.
    View in: PubMed
    Score: 0.002
  52. Radiation treatment of advanced or recurrent granulosa cell tumor of the ovary. Gynecol Oncol. 1999 Apr; 73(1):35-41.
    View in: PubMed
    Score: 0.002
  53. The current status of surgical staging of ovarian serous borderline tumors. Cancer. 1999 Feb 15; 85(4):905-11.
    View in: PubMed
    Score: 0.002
  54. A phase I study of a daily x3 schedule of intravenous vinorelbine for refractory epithelial ovarian cancer. Gynecol Oncol. 1998 Sep; 70(3):404-9.
    View in: PubMed
    Score: 0.002
  55. A phase II study of prolonged oral etoposide in advanced or recurrent carcinoma of the cervix. Gynecol Oncol. 1998 Aug; 70(2):215-8.
    View in: PubMed
    Score: 0.002
  56. Radiation therapy of pelvic recurrence after radical hysterectomy for cervical carcinoma. Gynecol Oncol. 1998 Aug; 70(2):241-6.
    View in: PubMed
    Score: 0.002
  57. Ovarian serous borderline tumors with invasive peritoneal implants. Cancer. 1998 Mar 15; 82(6):1096-103.
    View in: PubMed
    Score: 0.002
  58. Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix. J Clin Oncol. 1998 Mar; 16(3):1094-8.
    View in: PubMed
    Score: 0.002
  59. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med. 1997 Aug 15; 127(4):267-74.
    View in: PubMed
    Score: 0.002
  60. Prognostic significance of residual disease in patients with stage IV epithelial ovarian cancer. Gynecol Oncol. 1997 Jan; 64(1):13-7.
    View in: PubMed
    Score: 0.001
  61. Sexual adjustment of patients undergoing gracilis myocutaneous flap vaginal reconstruction in conjunction with pelvic exenteration. Cancer. 1996 Nov 15; 78(10):2229-35.
    View in: PubMed
    Score: 0.001
  62. A phase II Gynecologic Oncology Group trial of ifosfamide and mesna in advanced or recurrent adenocarcinoma of the endometrium. Gynecol Oncol. 1996 Oct; 63(1):25-7.
    View in: PubMed
    Score: 0.001
  63. Arterial occlusion complicating treatment of gynecologic cancer: a case series. Gynecol Oncol. 1996 Oct; 63(1):40-6.
    View in: PubMed
    Score: 0.001
  64. Adenocarcinoma in situ of the cervix: significance of cone biopsy margins. Obstet Gynecol. 1996 Jul; 88(1):82-6.
    View in: PubMed
    Score: 0.001
  65. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin. Obstet Gynecol. 1996 Apr; 87(4):527-31.
    View in: PubMed
    Score: 0.001
  66. Salvage chemotherapy for refractory transitional cell carcinoma of the ovary (TCC). Gynecol Oncol. 1995 Nov; 59(2):211-5.
    View in: PubMed
    Score: 0.001
  67. Potential applications of intraoperative lymphatic mapping in vulvar cancer. Gynecol Oncol. 1995 Nov; 59(2):216-20.
    View in: PubMed
    Score: 0.001
  68. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol. 1995 Oct; 59(1):38-44.
    View in: PubMed
    Score: 0.001
  69. Prolonged continuous infusion cisplatin and 5-fluorouracil with radiation for locally advanced carcinoma of the vulva. Gynecol Oncol. 1995 Oct; 59(1):51-6.
    View in: PubMed
    Score: 0.001
  70. Combined cisplatin and carboplatin chemotherapy for treatment of advanced epithelial ovarian cancer. Gynecol Oncol. 1995 Sep; 58(3):349-55.
    View in: PubMed
    Score: 0.001
  71. Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes. Gynecol Oncol. 1995 Aug; 58(2):189-93.
    View in: PubMed
    Score: 0.001
  72. Pelvic exenteration for primary and recurrent vulvar cancer. Gynecol Oncol. 1995 Aug; 58(2):202-5.
    View in: PubMed
    Score: 0.001
  73. Ovarian malignant mixed m?llerian tumors treated with platinum-based chemotherapy. Obstet Gynecol. 1995 May; 85(5 Pt 1):735-9.
    View in: PubMed
    Score: 0.001
  74. Treatment of locally advanced cervical cancer with concurrent radiation and intra-arterial chemotherapy. Gynecol Oncol. 1995 Apr; 57(1):72-8.
    View in: PubMed
    Score: 0.001
  75. Staging laparotomy for endometrial carcinoma: assessment of peritoneal spread. Gynecol Oncol. 1995 Jan; 56(1):34-8.
    View in: PubMed
    Score: 0.001
  76. Salvage surgery for chemorefractory gestational trophoblastic disease. J Clin Oncol. 1994 Dec; 12(12):2737-42.
    View in: PubMed
    Score: 0.001
  77. Radical hysterectomy for recurrent carcinoma of the uterine cervix after radiotherapy. Gynecol Oncol. 1994 Oct; 55(1):29-35.
    View in: PubMed
    Score: 0.001
  78. A phase II study of carboplatin and cisplatin in advanced or recurrent squamous carcinoma of the uterine cervix. Gynecol Oncol. 1994 May; 53(2):234-8.
    View in: PubMed
    Score: 0.001
  79. Intraoperative radiographs to confirm the adequacy of lymph node resection in patients with suspicious lymphangiograms. Gynecol Oncol. 1993 Dec; 51(3):362-7.
    View in: PubMed
    Score: 0.001
  80. Prognostic factors for patients undergoing simple hysterectomy in the presence of invasive cancer of the cervix. Gynecol Oncol. 1993 Aug; 50(2):179-84.
    View in: PubMed
    Score: 0.001
  81. Aborted exenterative procedures in recurrent cervical cancer. Gynecol Oncol. 1993 Jul; 50(1):94-9.
    View in: PubMed
    Score: 0.001
  82. Stage I cervical adenocarcinoma: prognostic evaluation of surgically treated patients. Gynecol Oncol. 1993 Apr; 49(1):19-23.
    View in: PubMed
    Score: 0.001
  83. Age contrasts in patients with advanced epithelial ovarian cancer. The M.D. Anderson Cancer Center experience. Cancer. 1993 Jan 15; 71(2 Suppl):638-43.
    View in: PubMed
    Score: 0.001
  84. Treatment of small cell carcinoma of the cervix with cisplatin, doxorubicin, and etoposide. Gynecol Oncol. 1992 Oct; 47(1):62-5.
    View in: PubMed
    Score: 0.001
  85. The effect of prolonged cisplatin-based chemotherapy on progression-free survival in patients with optimal epithelial ovarian cancer: "maintenance" therapy reconsidered. Gynecol Oncol. 1992 Oct; 47(1):7-13.
    View in: PubMed
    Score: 0.001
  86. Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC). Gynecol Oncol. 1992 Sep; 46(3):317-21.
    View in: PubMed
    Score: 0.001
  87. Minimally invasive vulvar carcinoma: an indication for conservative surgical therapy. Gynecol Oncol. 1992 Mar; 44(3):240-4.
    View in: PubMed
    Score: 0.001
  88. Clinical pharmacology, metabolism, and tissue distribution of 90Y-labeled monoclonal antibody B72.3 after intraperitoneal administration. J Natl Cancer Inst. 1991 Nov 20; 83(22):1629-36.
    View in: PubMed
    Score: 0.001
  89. Splenectomy in gynecologic oncology: indications, complications, and technique. Gynecol Oncol. 1991 Nov; 43(2):118-22.
    View in: PubMed
    Score: 0.001
  90. Early stage I adenocarcinoma of the uterine cervix: treatment results in patients with tumors less than or equal to 4 cm in diameter. Gynecol Oncol. 1991 Jun; 41(3):199-205.
    View in: PubMed
    Score: 0.001
  91. Unsuspected invasive squamous cell carcinoma of the vulva in young women. Gynecol Oncol. 1991 May; 41(2):182-5.
    View in: PubMed
    Score: 0.001
  92. Prognostic factors in stage IB squamous cervical cancer patients with low risk for recurrence. Obstet Gynecol. 1991 Feb; 77(2):271-5.
    View in: PubMed
    Score: 0.001
  93. Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide. Obstet Gynecol. 1990 Dec; 76(6):1020-4.
    View in: PubMed
    Score: 0.001
  94. Endometrioid carcinoma of the ovary: retrospective review of 145 cases. Gynecol Oncol. 1990 Dec; 39(3):337-46.
    View in: PubMed
    Score: 0.001
  95. Rapidly progressing cervical cancer in a patient with human immunodeficiency virus infection. Gynecol Oncol. 1990 Mar; 36(3):435-8.
    View in: PubMed
    Score: 0.001
  96. Estrogen replacement therapy following treatment for stage I endometrial carcinoma. Gynecol Oncol. 1990 Feb; 36(2):189-91.
    View in: PubMed
    Score: 0.001
  97. Intraoperative evaluation of depth of myometrial invasion in stage I endometrial adenocarcinoma. Obstet Gynecol. 1989 Dec; 74(6):930-3.
    View in: PubMed
    Score: 0.001
  98. Widespread lymph node metastases in a patient with microinvasive cervical carcinoma. Gynecol Oncol. 1989 Aug; 34(2):219-21.
    View in: PubMed
    Score: 0.001
  99. Methotrexate-induced erythema multiforme. Gynecol Oncol. 1989 Jun; 33(3):376-8.
    View in: PubMed
    Score: 0.001
  100. Determinants of survival of patients with epithelial ovarian carcinoma following whole abdomen irradiation (WAR). Gynecol Oncol. 1988 Jun; 30(2):201-8.
    View in: PubMed
    Score: 0.001
  101. Retroperitoneal nerve sheath tumors: an unusual cause of pelvic mass. Obstet Gynecol. 1988 Jun; 71(6 Pt 2):1050-2.
    View in: PubMed
    Score: 0.001
  102. The treatment of retroperitoneal fibromatosis with medroxyprogesterone acetate. Obstet Gynecol. 1987 Sep; 70(3 Pt 2):502-4.
    View in: PubMed
    Score: 0.001
  103. Retroperitoneal teratoma presenting as an abdominal-pelvic mass. Obstet Gynecol. 1987 Sep; 70(3 Pt 2):500-2.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.